These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7095749)

  • 41. Cathepsin G, a regulator of human vitamin K, dependent clotting factors and inhibitors.
    Turkington PT
    Thromb Res; 1992 Jul; 67(2):147-55. PubMed ID: 1440518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemistry of blood coagulation.
    Esnouf MP
    Br Med Bull; 1977 Sep; 33(3):213-8. PubMed ID: 334321
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS; Johnson FF; Robinson JA; Aggeler PM
    N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
    [No Abstract]   [Full Text] [Related]  

  • 44. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid.
    Furie B; Bouchard BA; Furie BC
    Blood; 1999 Mar; 93(6):1798-808. PubMed ID: 10068650
    [No Abstract]   [Full Text] [Related]  

  • 45. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
    Murano G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
    [No Abstract]   [Full Text] [Related]  

  • 46. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
    Suzuki K
    Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of vitamin K deficiency, warfarin, and inhibitors of protein synthesis upon the plasma levels of vitamin K-dependent clotting factors in the chick.
    Walz DA; Kipfer RK; Olson RE
    J Nutr; 1975 Aug; 105(8):972-81. PubMed ID: 1142015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence against vitamin K deficiency in normal neonates.
    Malia RG; Preston FE; Mitchell VE
    Thromb Haemost; 1980 Dec; 44(3):159-60. PubMed ID: 7466743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparin therapy in the case of acute liver cirrhosis.
    Fischer M; Gauss P; Korp W; Nobis H; Schnack B; Weissmann A
    Scand J Gastroenterol Suppl; 1973; 19():135-8. PubMed ID: 4515636
    [No Abstract]   [Full Text] [Related]  

  • 50. A plasma factor enhances activity of vitamin K-dependent coagulation proteins.
    Owens MR; Cimino CD
    Thromb Haemost; 1983 Oct; 50(3):749-52. PubMed ID: 6648895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defects in vitamin K-dependent carboxylation associated with moxalactam treatment.
    Barza M; Furie B; Brown AE; Furie BC
    J Infect Dis; 1986 Jun; 153(6):1166-9. PubMed ID: 3701122
    [No Abstract]   [Full Text] [Related]  

  • 52. The correlated actions of vitamin C, K, and Q.
    Quick AJ
    Life Sci; 1975 Apr; 16(7):1017-24. PubMed ID: 1094211
    [No Abstract]   [Full Text] [Related]  

  • 53. Vitamin K and the synthesis of factors VII-X by isolated rat liver cells.
    Ranhotra GS; Johnson BC
    Proc Soc Exp Biol Med; 1969 Nov; 132(2):509-13. PubMed ID: 5355100
    [No Abstract]   [Full Text] [Related]  

  • 54. Identification and purification of vitamin K-dependent proteins and peptides with monoclonal antibodies specific for gamma -carboxyglutamyl (Gla) residues.
    Brown MA; Stenberg LM; Persson U; Stenflo J
    J Biol Chem; 2000 Jun; 275(26):19795-802. PubMed ID: 10779512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a proteolytically modified form of human prothorombin.
    Dode C; Rabiet MJ; Bertrand O; Labie D; Elion J
    Biochem Biophys Res Commun; 1980 May; 94(2):660-6. PubMed ID: 6994725
    [No Abstract]   [Full Text] [Related]  

  • 56. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters.
    Jerkeman A; Astermark J; Hedner U; Lethagen S; Olsson CG; Berntorp E
    Thromb Res; 2000 Jun; 98(6):467-71. PubMed ID: 10899345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The liver and plasma coagulation factors. Physiology].
    Róka L
    Thromb Diath Haemorrh Suppl; 1973; 55():5-36. PubMed ID: 4612867
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of cyanate on the clotting proteins and platelet function.
    Hilgartner MW; Miller DR
    Proc Soc Exp Biol Med; 1975 May; 149(1):5-9. PubMed ID: 238214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of accessory components in the activation of vitamin K-dependent coagulation factors.
    van Rijn JL; Zwaal RF; Hemker HC; Rosing J
    Haemostasis; 1986; 16(3-4):216-26. PubMed ID: 3093336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of vitamin-K-dependent protein function by modification of the gamma-carboxyglutamic acid domain: studies of protein C and factor VII.
    Nelsestuen GL
    Trends Cardiovasc Med; 1999 Aug; 9(6):162-7. PubMed ID: 10639722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.